Yervoy is a brand name for the drug Ipilimumab, which is used to treat melanoma, a type of skin cancer. It works by stimulating the immune system to attack cancer cells. According to the sources provided, there are no specific requirements for Yervoy discounts. However, the drug is expensive and may not be covered by all insurance plans.
Drugpatentwatch [1] provides information on the patent status of Yervoy and its generic alternatives. As of August 2021, the patent for Yervoy is set to expire in October 2022. This means that generic versions of the drug may become available after that date, which could potentially lower the cost.
Drugs.com [2] provides a price guide for Yervoy, which shows that the average retail price for a 1mg vial is around $8,500. However, the actual price may vary depending on the pharmacy and location. The website also offers a discount card that can be used to save up to 75% on the cost of Yervoy. This card is available to anyone and can be used regardless of insurance coverage.
NiceRx [3] is a prescription assistance program that helps people access expensive medications, including Yervoy. The program offers discounts and copay assistance to eligible individuals who meet certain income and insurance criteria. To qualify, patients must have a prescription for Yervoy and meet the program's income requirements. NiceRx also provides assistance with the application process and can help patients navigate the insurance system.
In conclusion, while there are no specific requirements for Yervoy discounts, the drug is expensive and may not be covered by all insurance plans. Patients may be able to save money by using a discount card or prescription assistance program like NiceRx. Additionally, the expiration of the drug's patent in October 2022 may lead to the availability of generic versions, which could potentially lower the cost.
Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/YERVOY
[2] https://www.drugs.com/price-guide/yervoy
[3] https://www.nicerx.com/medications/yervoy/